UV Radiation: Balancing Risks and Benefits

被引:172
|
作者
McKenzie, Richard L. [1 ]
Liley, J. Ben [1 ]
Bjorn, Lars Olof [2 ]
机构
[1] Natl Inst Water & Atmospher Res, Lauder, Central Otago, New Zealand
[2] Lund Univ, Lund, Sweden
关键词
VITAMIN-D STATUS; NEW-ZEALAND; SKIN; IRRADIANCE; HEALTH; 25-HYDROXYVITAMIN-D; SUNSCREENS; PROTECTION; EXPOSURE; SUNLIGHT;
D O I
10.1111/j.1751-1097.2008.00400.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We use action spectra published by the International Commission on Illumination to examine diurnal, seasonal and latitudinal variations in erythemally weighted (sunburning) UV-a health risk, and vitamin D-weighted UV-a health benefit. Vitamin D-weighted UV is more strongly dependent on ozone and solar zenith angle. Consequently, its diurnal, seasonal and geographic variability is more pronounced than for erythemally weighted UV. We then investigate relationships between the two quantities. An algorithm is developed and used to relate vitamin D production to the widely used UV index, to help the public to optimize their exposure to UV radiation. In the summer at noon, there should at mid-latitudes be sufficient UV to photosynthesize optimal vitamin D in similar to 1 min for full body exposure, whereas skin damage occurs after similar to 15 min. Further, while it should be possible to photosynthesize vitamin D in the winter at mid-latitudes, the amount of skin that must be exposed is larger than from the hands and face alone. This raises the question of whether the action spectrum for vitamin D production is correct, since studies have reported that production of vitamin D is not possible in the winter at mid-latitudes.
引用
收藏
页码:88 / 98
页数:11
相关论文
共 50 条
  • [1] Radiation Safety in Emergency Medicine: Balancing the Benefits and Risks
    Azman, Raja Rizal
    Shah, Mohammad Nazri Md
    Ng, Kwan Hoong
    [J]. KOREAN JOURNAL OF RADIOLOGY, 2019, 20 (03) : 399 - 404
  • [3] Tamoxifen, balancing risks and benefits
    Bergman, L
    Benraadt, J
    vanLeeuwen, FE
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 1996, 49 (06): : 228 - 234
  • [4] Balancing the Risks and Benefits of Rituximab
    Linos, Eleni
    [J]. JAMA INTERNAL MEDICINE, 2013, 173 (10) : 926 - 926
  • [5] NSAIDs Balancing the Risks and Benefits
    Gorczyca, Pamela
    Manniello, Marina
    Pisano, Michele
    Avena-Woods, Carmela
    [J]. US PHARMACIST, 2016, 41 (03) : 24 - 35
  • [6] Balancing the risks and benefits in AMD
    Beaumont, PE
    Kang, HK
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2005, 33 (01): : 108 - 110
  • [7] ECT - BALANCING RISKS AND BENEFITS
    MATHERS, J
    [J]. BRITISH MEDICAL JOURNAL, 1980, 280 (6218): : 941 - 941
  • [8] ECT - BALANCING RISKS AND BENEFITS
    BEBBINGTON, P
    BENNETT, DH
    BIRLEY, JLT
    CLARE, AW
    CUTTING, J
    KUMAR, R
    MANN, AH
    MULLEN, P
    RON, M
    WILLIAMS, P
    [J]. BRITISH MEDICAL JOURNAL, 1980, 280 (6216): : 792 - 792
  • [9] Balancing the risks and benefits of celecoxib
    Caldwell, Brent
    Beasley, Richard
    Weatherall, Mark
    Metcalfe, Scott
    [J]. AMERICAN JOURNAL OF MEDICINE, 2007, 120 (06): : E17 - E17
  • [10] ECT - BALANCING RISKS AND BENEFITS
    BROWN, JH
    [J]. BRITISH MEDICAL JOURNAL, 1980, 280 (6225): : 1228 - 1228